Search by Drug Name or NDC
NDC 25021-0671-66 ropivacaine hydrochloride 2 mg/mL Details
ropivacaine hydrochloride 2 mg/mL
ropivacaine hydrochloride is a EPIDURAL; INFILTRATION INJECTION, SOLUTION in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by Sagent Pharmaceuticals. The primary component is ROPIVACAINE HYDROCHLORIDE.
Product Information
| NDC | 25021-0671 |
|---|---|
| Product ID | 25021-671_ae84a6fa-62a4-4e50-9d5d-01197c4f8f34 |
| Associated GPIs | 69100070102008 |
| GCN Sequence Number | 028217 |
| GCN Sequence Number Description | ropivacaine HCl/PF VIAL 2 MG/ML INJECTION |
| HIC3 | H0A |
| HIC3 Description | LOCAL ANESTHETICS |
| GCN | 46081 |
| HICL Sequence Number | 036674 |
| HICL Sequence Number Description | ROPIVACAINE HCL/PF |
| Brand/Generic | Generic |
| Proprietary Name | ropivacaine hydrochloride |
| Proprietary Name Suffix | n/a |
| Non-Proprietary Name | ropivacaine hydrochloride |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Dosage Form | INJECTION, SOLUTION |
| Route | EPIDURAL; INFILTRATION |
| Active Ingredient Strength | 2 |
| Active Ingredient Units | mg/mL |
| Substance Name | ROPIVACAINE HYDROCHLORIDE |
| Labeler Name | Sagent Pharmaceuticals |
| Pharmaceutical Class | Amide Local Anesthetic [EPC], Amides [CS], Local Anesthesia [PE] |
| DEA Schedule | n/a |
| Marketing Category | ANDA |
| Application Number | ANDA206166 |
| Listing Certified Through | 2024-12-31 |
Package
NDC 25021-0671-66 (25021067166)
| NDC Package Code | 25021-671-66 |
|---|---|
| Billing NDC | 25021067166 |
| Package | 10 BAG in 1 CARTON (25021-671-66) / 100 mL in 1 BAG |
| Marketing Start Date | 2020-01-01 |
| NDC Exclude Flag | N |
| Pricing Information | N/A |